3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
71
Colorectal Neoplasms
34
Rectal Neoplasms
33
Esophageal Neoplasms
25
Carcinoma, Non-Small-Cell Lung
24
Esophageal Squamous Cell Carcinoma
23
Pancreatic Neoplasms
16
Stomach Neoplasms
15
Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
14
Adenocarcinoma Of Esophagus
14
Sarcoma
11
Ovarian Neoplasms
11
Lung Neoplasms
11
Colonic Neoplasms
11
Carcinoma, Hepatocellular
11
Prostatic Neoplasms
10
Head and Neck Neoplasms
10
Neoplasm Metastasis
9
Urinary Bladder Neoplasms
8
Uterine Cervical Neoplasms
7
Recurrence
6
Osteosarcoma
6
Multiple Myeloma
5
Fallopian Tube Neoplasms
5
Carcinoma, Intraductal, Noninfiltrating
5
Breast Carcinoma In Situ
5
Peritoneal Neoplasms
4
Nasopharyngeal Carcinoma
4
Locally Advanced Rectal Cancer
4
Interventions
Cyclophosphamide
77
Dexamethasone
74
Melphalan
65
Lenalidomide
50
Bortezomib
50
Peripheral Blood Stem Cell Transplantation
49
fludarabine phosphate
47
Busulfan
46
Filgrastim
39
Tacrolimus
37
Antilymphocyte Serum
33
Radiotherapy
30
Mycophenolic Acid
30
Thalidomide
28
fludarabine
24
Methotrexate
22
Whole-Body Irradiation
21
Cyclosporine
21
Calcium Dobesilate
21
Granulocyte Colony-Stimulating Factor
18
Methylprednisolone
17
Etoposide
17
Cord Blood Stem Cell Transplantation
14
daratumumab
11
Prednisone
11
Carmustine
11
sargramostim
10
Stem Cell Transplantation
10
Sirolimus
10
Rituximab
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Plasma Cell
×
Neoadjuvant Therapy
×
Clear all
NCT01554852
2018-06-11
Myeloma XI
University of Leeds
Phase 3
Unknown
4,420 enrolled